Hormone replacement therapy and osteoporosis.
Restoration of the osteoporotic skeleton is difficult. Factors that may aggravate the bone loss or increase the risk of fractures should be eliminated. The physician may then decide whether the patient is a candidate for one of the treatments which either stop further bone loss or increase the bone mass. The decision should be based on a variety of factors and be taken together with the patient.
Christiansen
C
C
Center for Clinical and Basic Research, Ballerup, Denmark.
D000328:Adult; D000368:Aged; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D002979:Climacteric / Q000187:drug effects; D015914:Estrogen Replacement Therapy; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D011372:Progestins / Q000008:administration & dosage; D016896:Treatment Outcome
D011372:Progestins